{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["11(2)"],"submitter":["Wieck MM"],"pubmed_abstract":["<h4>Rationale</h4>Neonatal respiratory distress syndrome is a restrictive lung disease characterized by surfactant deficiency. Decreased vascular endothelial growth factor (VEGF), which demonstrates important roles in angiogenesis and vasculogenesis, has been implicated in the pathogenesis of restrictive lung diseases. Current animal models investigating VEGF in the etiology and outcomes of RDS require premature delivery, hypoxia, anatomically or temporally limited inhibition, or other supplemental interventions. Consequently, little is known about the isolated effects of chronic VEGF inhibition, started at birth, on subsequent developing lung structure and function.<h4>Objectives</h4>To determine whether inducible, mesenchyme-specific VEGF inhibition in the neonatal mouse lung results in "],"journal":["PloS one"],"pagination":["e0148323"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC4749176"],"repository":["biostudies-literature"],"pubmed_title":["Sequestration of Vascular Endothelial Growth Factor (VEGF) Induces Late Restrictive Lung Disease."],"pmcid":["PMC4749176"],"pubmed_authors":["Reddy R","Driscoll B","Wieck MM","Lee J","Grikscheit TC","Navarro S","Levin DE","Hou X","Spurrier RG","Mojica SG","Hiatt MJ","Lundin A"],"additional_accession":[]},"is_claimable":false,"name":"Sequestration of Vascular Endothelial Growth Factor (VEGF) Induces Late Restrictive Lung Disease.","description":"<h4>Rationale</h4>Neonatal respiratory distress syndrome is a restrictive lung disease characterized by surfactant deficiency. Decreased vascular endothelial growth factor (VEGF), which demonstrates important roles in angiogenesis and vasculogenesis, has been implicated in the pathogenesis of restrictive lung diseases. Current animal models investigating VEGF in the etiology and outcomes of RDS require premature delivery, hypoxia, anatomically or temporally limited inhibition, or other supplemental interventions. Consequently, little is known about the isolated effects of chronic VEGF inhibition, started at birth, on subsequent developing lung structure and function.<h4>Objectives</h4>To determine whether inducible, mesenchyme-specific VEGF inhibition in the neonatal mouse lung results in ","dates":{"release":"2016-01-01T00:00:00Z","publication":"2016","modification":"2025-05-29T22:27:07.635Z","creation":"2025-05-29T22:27:07.635Z"},"accession":"S-EPMC4749176","cross_references":{"pubmed":["26863115"],"doi":["10.1371/journal.pone.0148323"]}}